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Background: The melanoma differentiation-associated gene-7 (mda-7)/interleukin-24 (IL-24) can induce apoptosis
in a wide variety of tumor cell types, whereas it has no toxicity in normal cells. However, recombinant human
mda-7/IL-24 is difficult to obtain from Escherichia coli because of its insolubility.
Results: In this study, we improved the structure of inclusion bodies (IBs) by optimizing the induction temperature,
pH, concentrations of inducer, and metal ion additives. Statistically designed experimental analyses of three metal
ion factors were performed using the Box-Behnken design. Induction temperature of 30°C, pH 7.0, and 0.1 mM
isopropyl-β-D-thiogalactopyranoside (IPTG) were selected, and the optimized levels for the factors predicted by the
model comprised the following: Mg2+ (15.7 mM), Ca2+ (16.6 mM), and Mn2+ (3.0 mM). The optimized culture
conditions improved the structure of the IBs, which was validated by scanning electron microscopy (SEM) and the
increase of IBs solubility.
Conclusions: After optimization, IB solubility and renatured mda-7/IL-24 increased by 51% and 84%, respectively.
This study also provided a simple purification method of specific IB washing steps. Manipulating the fermentation
parameters to optimize the refolding and purification process is likely to be widely applicable to other proteins.
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The World Cancer Report 2014 emphasized the urgent
need for efficient prevention strategies to curb cancer.
In 2012, the global cancer burden rose to an estimated
14 million new cases per year, which is expected to rise
to 22 million per year within the next 20 years. Thus,
studies are searching for the ‘Holy grail’ of cancer treat-
ment, which can selectively destroy tumor cells without
eliciting harmful effects on normal cells or tissues, and
melanoma differentiation-associated gene-7 (mda-7)/
interleukin-24 (IL-24) appears to be a possible candidate
[1]. The mda-7 is a novel tumor cell-specific apoptosis-
inducing gene, and it was identified via a subtraction* Correspondence: sunaiyou@ecust.edu.cn; xdwang@ecust.edu.cn
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in any medium, provided the original work is phybridization approach from human melanoma cells that
were stimulated into growth arrest and terminal differenti-
ation by treatment with fibroblasts of IFN and mezerein
[2]. Subsequently, mda-7 has been classified as a member
of the expanding IL-10 gene family and it was designated
as IL-24 [3,4]. mda-7/IL-24 has apoptosis-inducing prop-
erties in a broad spectrum of human tumors [5-7]. It also
has a potent ‘bystander’ activity [8], inhibits tumor angio-
genesis [9], induces antitumor immunity, and synergizes
with radiation and other chemotherapeutic agents [10].
Gene therapy of mda-7/IL-24 is currently undergoing
phase II clinical trials [11,12], and it is a promising target
in the field of antitumor drug research.
The Escherichia coli expression system is most widely
used for producing large quantities of recombinant pro-
teins [13]. However, mda-7/IL-24 protein is prone to
form pyknotic inclusion bodies (IBs) when expressed inn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.






A: MgSO4 1.50 2.00 2.50
B: CaCl2 1.00 1.50 2.00
C: MnSO4 0.50 0.75 1.00
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Solubilization and renaturation steps have an extremely
significant effect on the overall process for preparation
of biological active protein. Inefficient solubilization re-
sults in the reformation of aggregates during the subse-
quent renaturation steps [17,18]. Thus, the structural
characteristics of IBs could affect their solubilization effi-
ciency [19]. There were many studies about the refolding
methods of IBs in vitro [20-22]. However, no previous
studies have attempted to improve the structure of mda-
7/IL-24 IBs by optimizing the culture conditions to fa-
cilitate the subsequent IB renaturation and purification
process. In this study, we evaluated the correlation be-
tween the IB solubilization behavior and culture condi-
tions. Furthermore, we assessed the effects of metal ions
of Mg2+, Ca2+, and Mn2+ and their interactions using a
statistically designed experiment (Box-Behnken design)




The entire cDNA of the human mda-7/IL-24 gene [Gen-
Bank:NM-006850] was stored in our laboratory. Two oligo-
nucleotide primers were designed, forward (5′-GGGAAT
TCCATATGGCCCAGGGCCAAGAATTCCACT-3′) and
reverse (5′-CCCAAGCTTGGGTCAGAGCTTGTAGAAT
TTCTG-3′), to introduce the Nde I and Hind III restriction
endonucleases (Takara Bio Inc., Otsu, Shiga, Japan), re-
spectively. The mda-7/IL-24 gene was obtained by PCR
with the primers. The resulting products were subcloned
into the pET28a (+) expression vector after double diges-
tion. The recombinant plasmid pET28a-mda-7/IL-24 was
transformed into BL21 (DE3) pLysS competent cells. The
sequence was confirmed by DNA sequencing (Shanghai
Jieli Biotechnology Co., Ltd., Shanghai, China).
Expression of the recombinant human mda-7/IL-24
The recombinant E. coli BL21 (DE3) pLysS was inocu-
lated into 250 mL Luria-Bertani (LB) medium, incubated
at 37°C with shaking at 200 rpm. When the OD600 of
the cultured medium reached 0.6, the culture was in-
duced with isopropyl-β-D-thiogalactopyranoside (IPTG)
at a final concentration of 1 mM for 4 h. Further, the
cells were harvested by centrifugation at 8,000×g for
10 min at 4°C, and the pellets were resuspended in lysate
buffer (20 mM Tris, 10 mM EDTA, pH 8.5) before
disruption, where the sonication program comprised a
series of 200 × 3 s bursts at 300 to 400 W power with a
6-s pause between each burst. The samples were then
subjected to centrifugation at 10,000×g for 30 min.
Protein expression was analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE:
15% separating gel and 4% stacking gel).Culture conditions
The effects of the culture conditions were studied,
including the induction temperatures (18°C, 25°C, 30°C,
and 37°C), pH (6.0, 7.0, 8.0, and 9.0), IPTG concentra-
tions (0.1, 0.5, 1.0, and 1.5 mM), and the addition of dif-
ferent metal ions (Mg2+, Fe3+, Ca2+, Na+, NH4+, Mn2+,
Cu2+, and K+ at concentrations of 0.50, 1.00, 2.00, and
3.00 g/L). The corresponding compounds were MgSO4, Fe2
(SO4)3, CaCl2, NaCl, NH4Cl, MnSO4·H2O, CuSO4·5H2O,
and KCl. Each experiment was repeated twice with three
replicates.
Furthermore, we optimized the concentrations of the
metal ions using a Box-Behnken design [23,24] to
minimize the IB solubility. The Design-Expert Software
(version 8.0, Stat-Ease Inc., Minneapolis, MN, USA) was
used for the experimental design and data analysis.
Three variables were designed at three levels, which
required 17 experiments. The minimum and maximum
levels are described in Table 1. All experiments were
performed in triplicate, where the response Y repre-
sented the average value. The optimal values were ob-
tained by solving the regression equation and analyzing
three-dimensional (3D) response surface plots and con-
tour plots.Solubility of the IBs
mda-7/IL-24 was produced in different culture condi-
tions using 30 mL LB medium in a 250-mL shaker flask.
The IBs were obtained by centrifugation after disruption.
The same amount of enriched IBs (1 mg) was resus-
pended in 1 mL solubilization buffer (8 M urea) and vor-
texed for 2 h at room temperature. The IB solubility will
be affected by their structures, which will result in differ-
ence in turbidity when IBs were dissolved in denatur-
ation buffer. The turbidity of IB resuspension in the
solubilization buffer was chosen as the index to reflect
the solubility of IBs, and lower turbidities were associ-
ated with higher IB solubilities [25,26]. The turbidity of
the suspension was measured at 480 nm.
The samples were centrifuged at 13,000×g for 30 min
and filtrated through a 0.45-μm Millipore filter (Millipore
Co., Billerica, MA, USA). The protein content was esti-
mated by using micro-BCA kit (Beijing Solarbio Science
& Technology Co., Ltd., Beijing, China).















Buffer I 2 10 20 100 1 8.5
Buffer II 4 10 20 0 2 8.5
Buffer III 2 10 20 0 1 9.5
Deionized water 0 0 0 0 0 6.5 to 7.0
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After disruption, the enriched IBs were solubilized and
refolded. mda-7/IL-24 IBs were washed using ‘3 + 1’
washing buffers (about 1 g IBs were solubilized in 30 mL
washing buffer): buffer I, buffer II, buffer III, and deion-
ized water (Table 2). In each step, the IBs were resus-
pended in washing buffer and agitated for 2 h. Then, the
IBs were harvested by centrifugation at 10,000×g for
30 min. After these washing steps, high-purity IBs of
mda-7/IL-24 were obtained.
Further, the high-purity IBs were dissolved in a buffer so-
lution (20 mM Tris, 10 mM EDTA, and 8 M urea, pH 9.0)
and stirred overnight to facilitate denaturation of the
mda-7/IL-24 protein. Renatured mda-7/IL-24 protein was
achieved by dialysis (the concentration of mda-7/IL-24 was
0.10 mg/mL at the beginning of dialysis) with the decrease
of urea concentrations (6, 3, 1.5, 0.75, and 0 M), where each
dialysis buffer was applied for 12 h at 4°C with mild
agitation. Finally, the bioactive mda-7/IL-24 protein was di-
alyzed in phosphate-buffered saline (PBS) (50 mM, pH 7.4).Western blot assay
The SDS-PAGE analysis was performed using 15% SDS-
polyacrylamide gels. The proteins retained in the gelsFigure 1 SDS-PAGE and western blot analysis of mda-7/IL-24. (A) SDS
molecular weight markers; lanes 1 to 2, whole cell lysate of pET28a-mda-7/
after induction by IPTG; lane 4, soluble fractions of cell lysate after inductio
western blot analysis of mda-7/IL-24; lane 2, blank control without anti-humwere detected using Coomassie brilliant Blue R-250 or
they were transferred by electrophoresis to nitrocellulose
membranes for western blot analysis [27]. The mem-
branes were probed with anti-mda-7/IL-24 polyclonal
antibodies (R&D Systems, Minneapolis, MN, USA). A
secondary antibody conjugated to horseradish peroxid-
ase was used to enhance the chemiluminescence.Scanning electron microscopy
Optimized and non-optimized IBs were also analyzed by
scanning electron microscopy (SEM). The IBs after water
dialysis were fixed and frozen [19] and dehydrated using a
vacuum freeze dryer (Scientz-10N, Ningbo Scientz
Biotechnology Co., Ltd., Ningbo City, China). Then, the
samples were covered with gold, viewed, and photo-
graphed using a scanning electron microscope (S-3400N),
Hitachi, Ltd., Chiyoda, Tokyo, Japan).MTT assay
Proliferation inhibition was measured based on the 3-
(4,5-dimethylazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. Human breast cancer cell line MCF-7, hu-
man malignant melanoma cell line A-375, and normal
human lung fibroblast (NHLF) cell line were plated onto
96-well microtiter plates (8 × 103 cells/well) in Dulbec-
co's modified Eagle's medium (DMEM) supplemented
with 10% fetal bovine serum and incubated at 37°C with
5% CO2. After 24 h, the cells were treated with mda-7/
IL-24 at varying concentrations for 48 h and PBS as con-
trol. The surviving cells were detected by adding 20 μL
MTT (5 mg/mL) and incubating for 4 h. The resulting
absorbance measured at 490 nm was proportional to the
number of viable cells.-PAGE analysis of mda-7/IL-24 expressed in E. coli. Lane M, protein
IL-24 uninduced and induced; lane 3, insoluble fractions of cell lysate
n by IPTG. (B) Western blot analysis of mda-7/IL-24 protein. Lane 1,
an mda-7/IL-24 antibody.
Figure 2 Influence of culture conditions on mean turbidity (±SD). (A) The effects of different induction temperatures on turbidity. (B) The
effects of different IPTG concentrations on turbidity. (C) The effects of different pH values on turbidity. (D) The effects of different metal ions
(2.00 g/L) on turbidity. The mda-7/IL-24 expressions analyzed by SDS-PAGE in corresponding conditions are placed above each graph.




Factors coded Response OD480
A B C Actual value Predicted value
1 −1 −1 0 3.492 3.562
2 1 −1 0 2.738 2.769
3 −1 1 0 2.274 2.244
4 1 1 0 2.536 2.466
5 −1 0 −1 2.419 2.393
6 1 0 −1 2.203 2.216
7 −1 0 1 2.574 2.561
8 1 0 1 2.139 2.165
9 0 −1 −1 3.319 3.275
10 0 1 −1 1.945 2.002
11 0 −1 1 2.928 2.871
12 0 1 1 2.479 2.523
13 0 0 0 2.013 2.075
14 0 0 0 2.273 2.075
15 0 0 0 1.996 2.075
16 0 0 0 1.892 2.075
17 0 0 0 2.202 2.075
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Expression of mda-7/IL-24
Recombinant plasmid pET28a-mda-7/IL-24 was obtained
successfully, which contained a sequence of 474-bp coding
sequence for 158 amino acid residues, and produced ap-






F value Prob > F Remark
Model 3.3000 9 0.3700 20.8900 0.0003 Significant
A 0.1633 1 0.1633 9.3161 0.0185 Significant
B 1.3146 1 1.3146 74.9956 <0.0001 Significant
C 0.0068 1 0.0068 0.3905 0.5519
AB 0.2581 1 0.2581 14.7218 0.0064 Significant
AC 0.0120 1 0.0120 0.6840 0.4355
BC 0.2139 1 0.2139 12.2027 0.0101 Significant
A2 0.1295 1 0.1295 7.3897 0.0298 Significant
B2 1.0926 1 1.0926 62.3285 <0.0001 Significant
C2 0.0291 1 0.0291 1.6607 0.2835
Residual 0.1227 7 0.0175
Lack of fit 0.0238 3 0.0079 0.3208 0.8113 Not significant
Pure error 0.0989 4 0.0247
Cor total 3.4189 16
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most of which was present as IBs. The western blot ana-
lysis confirmed that mda-7/IL-24 was recognized by the
anti-IL-24 monoclonal antibody (Figure 1B).Figure 3 Three-dimensional response surface curve showing the effec
(C) Ca2+ and Mn2+.Culture condition optimization by response surface
methodology
The factors that are known to affect the protein solubility
include plasmid copy number, culture media, bacterialts of metal ion additives. (A) Mg2+ and Ca2+. (B) Mg2+ and Mn2+.
Figure 4 IB characteristics determined by SEM. (A, C, E) IBs produced before optimization. (B, D, F) IBs produced after optimization.














105 68 - 65
Buffer I 84 61 89 73
Buffer II 65 56 92 86
Buffer III 53 49 88 92
Deionized
water
50 48 98 96
The wet weight of the E. coli cells was 3.75 g from 1 L culture medium, and
105 mg IBs was obtained after disruption. mda-7/IL-24 comprised up to 30%
of the total protein. The total target protein lost 29% during the washes and
8.4% during the dialysis. The final purity of mda-7/IL-24 was about 95%.
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centration of the inducer [28,29]. We tried to improve the
structure of mda-7/IL-24 IBs by optimizing the culture
conditions to facilitate the subsequent IB renaturation and
purification process. In this study, turbidity was used as a
quantitative index of IB solubility. The effects of culture
conditions on turbidity are shown in Figure 2. Conditions
which could significantly reduce the turbidity of IB sus-
pension without markedly reducing the mda-7/IL-24
protein expression were chosen. As a result, we selected
an induction temperature of 30°C, pH 7.0, and 0.1 mM
IPTG. Culture additives of Mg2+, Ca2+, and Mn2+ had
positive effects on reducing the turbidity compared with
the control, where the turbidity was decreased by 11%,
16%, and 7.0%, respectively. In contrast, Na+, NH4
+, K+,
and Cu2+ had no obvious effects, whereas Fe3+ increased
the turbidity greatly.
To achieve the maximum solubilization of mda-7/IL-
24 IBs, we optimized the IB turbidity using the Box-
Behnken design, which included metal ion additives, i.e.,
(A) Mg2+, (B) Ca2+, and (C) Mn2+. The design matrix
and the results of the 17 experiments conducted using
the Box-Behnken design are described in Table 3, which
comprised 12 trials plus five center points. The results
obtained were analyzed by ANOVA using the Design-Expert Software (version 8.0 Stat-Ease Inc.). The regres-
sion model used was as follows:
Y OD480ð Þ ¼ þ 16:38667 − 4:28765A − 10:34305B
− 3:77760C þ 1:01600AB − 0:43800AC
þ 1:85000BC þ 0:70160A2
þ 2:03760B2 þ 1:33040C2
ð1Þ
Figure 5 The SDS-PAGE analysis of mda-7/IL-24 after ‘3 + 1’
washing steps. Lane M, protein molecular weight markers; lane 1,
supernatant of bacteria lysate; lanes 2, 4, and 5, pellets washed by
washing buffers I, II, III, respectively; lanes 3, 6, 7, supernatants after
each wash steps (I, II, and III wash steps, respectively); lane 8, the
final pellets after ‘3 + 1’ washing steps.
















Control 3.921 - 13 -
Temperature 3.383 14 16 22
IPTG 3.672 6 14 9.0
pH Not significant - - -
Metal ion
additives
1.94 51 23 84
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are shown in Table 4. The model F value of 20.89 im-
plied that the model was significant, i.e., there was only
a 0.03% chance that a ‘model F value’ this large could
occur due to noise. The coefficient of determination (R2)
was used to check the goodness of fit of the model
(Table 4), where R2 was 0.9641. The value of the ad-
justed coefficient of determination (adjusted R2 = 0.9180)
agreed reasonably well with the predicted R2 (0.8434).
The lack-of-fit value for the regression of Equation 1
was not significant (0.8113), thereby indicating that the
model equation was suitable for predicting the turbidity
with any combination of values for the variables. ‘Adeq
Precision’ measures the signal-to-noise ratio, where a
ratio greater than four is considered to be desirable [30].
The ‘Adeq Precision’ ratio of 15.336 obtained in the
present study indicated an adequate signal. Thus, this
model can be used to navigate the design space.Figure 6 The activity of renatured mda-7/IL-24 (±SD). mda-7/IL-24
inhibits the survival of A375 and MCF-7 cells in a concentration-
dependent manner, whereas it has little effect on the growth of NHLFs.The effects of the addition of metal ions, i.e., (A) Mg2+,
(B) Ca2+, and (C) Mn2+, on IB solubilization were visu-
alized using 3D response surface and contour plots in
(Figure 3). The 3D graphs were generated based on the
response of pairwise combinations of the three factors
while keeping the other at its optimum level. The
graphs are shown to demonstrate the effects of various
factors on the turbidity. The interaction effect of Mg2+
and Ca2+ is shown in Figure 3A. Ca2+ exhibited a quad-
ratic response and it was the major factor, while Mg2+
also exhibited a quadratic response. These data sug-
gested that the Mg2+ and Ca2+ had significant effects
on turbidity, and they also had significant interaction
effects on each other. The interaction effect of Mg2+
and Mn2+ is shown in Figure 3B. The effects of Mn2+
and its quadratic response were not significant, while
Mg2+ and Mn2+ also had non-significant interaction
effects on each other. However, Ca2+ and Mn2+ had sig-
nificant interaction effects on each other, where theFigure 7 Bacteria growth (OD600) and mda-7/IL-24 protein
production (mg/mL) before and after optimization. E. coli were
grown in a 30 mL culture medium. Dotted lines represent values of
mean OD600 (±SD), without optimization (…■…) and with optimization
(…○…). Solid lines represent values of protein production (±SD),
without optimization (―■―) and after optimization (―○―).
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(Figure 3C).
A validation was performed using the conditions pre-
dicted by the model. The optimized levels predicted by the
model were as follows: Mg2+ (15.7 mM), Ca2+ (16.6 mM),
and Mn2+ (3.0 mM). The predicted turbidity was 1.92
(suspension measured at 480 nm), and the actual obtained
was 1.94. The exact correlation between the experimental
and predicted values validated this model.
IB characteristics determined by SEM
The structures of the IBs were also examined by SEM
(Figure 4). It was clear that IBs without optimization
were much larger, and the particles stuck together tightly
(Figure 4A,C,E). While IBs with optimization had a
more regular shape and appeared to be much looser,
even single particles could be observed (Figure 4B,D,F).
Simplified purification process
In our study, IBs comprised up to approximately 100%
of the total mda-7/IL-24 even after these optimizations.
mda-7/IL-24 IBs were barely dissolved in both 8 M urea
and 6 M guanidine hydrochloride. A ‘3 + 1’ IB washing
process was designed. High concentration of urea and
Triton X-100 could effectively remove the impurities,
while the pyknotic mda-7/IL-24 IBs were not completely
removed in the washing steps. The purity of mda-7/IL-
24 after ‘3 + 1’ steps was 96% (Table 5, Figure 5). This
was a simplified purification process, which required no
additional procedures, such as affinity chromatography
purification.
Bioactivity of mda-7/IL-24
The results showed that mda-7/IL-24 had negligible
inhibitory effects on NHLF cells, while it had cytotoxicity
effects on MCF-7 cells and A375 cells in a concentration-
dependent manner, and the 50% inhibitory concentrations
were about 1.0 and 0.7 μg/mL, respectively (Figure 6).
Conclusions
Recombinant protein is prone to form IBs when expressed
in E. coli. Recombinant human mda-7/IL-24 IBs are diffi-
cult to refold due to its low solubility [14]. Some studies
tried to obtain soluble expression or easy refolding of
mda-7/IL-24 using genetic methods [15,16,31]. However,
no previous study has attempted to improve the structure
of mda-7/IL-24 IBs by optimizing the culture conditions
to facilitate the subsequent IB renaturation and purifica-
tion. In this study, culture conditions were optimized,
which increased the solubility of mda-7/IL-24 IBs by
approximately 51% (Table 6). We speculated that the
optimized culture conditions improved the IB structure,
which was validated by SEM and the increase of solubility.The renatured protein almost had the same activity as the
commercial product of mda-7/IL-24 (Cloud-Clone Corp.,
Houston, TX, USA) expressed in E. coli. Therefore, we
confirmed the activities of the renatured mda-7/IL-24
protein and did not evaluate the proportion of the active
proteins. Efficient solubilization could contribute to the
performance of the subsequent renaturation steps [17,18],
and the renatured mda-7/IL-24 protein increased by 84%
in our experiments (Table 6).
The ‘3 + 1’ washing steps could gradually remove the
miscellaneous proteins and also make the IB particles
loose, which benefited the subsequent refolding process.
As a result, the purity of mad-7/IL-24 was 96% after ‘3 + 1’
washing steps. Therefore, the ‘3 + 1’ washing approach
based on these IB structural characters was a simplified
purification process.
With the optimized conditions, the mda-7/IL-24 forma-
tion rate was slower during the early stage and faster
during the late stage (Figure 7). This may be due to some
proteins being synthesized in the early stage that facilitated
the correct folding of the mda-7/IL-24 protein, thereby
allowing the IBs to possess a greater proportion of native-
like secondary structure [32]. Therefore, the structure of
IBs was improved and the solubility of the IBs in-
creased. It is an important method to optimize the
renaturation and purification process by manipulating
the fermentation parameters [33]. This approach may
also be applied to the expression of other proteins with
similar structural characteristics.
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